Ben Hirschler

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

11:40am IST

China biotech's 'coming out party' masks long road ahead

LONDON/SHANGHAI Investors are betting on China's potential to feed the global pharmaceutical pipeline, putting a multi-billion-dollar price tag on a handful of stocks, even as the country struggles to close a huge R&D gap with the West.

16 Oct 2017

Pharma and medtech industries prepare for hard Brexit

LONDON Drugmakers and medical devices companies are drawing up plans to protect supply chains in case Britain crashes out of the European Union without a trade deal, and some small service businesses are already relocating to stay inside the bloc.

10 Oct 2017

Pfizer weighs $15 billion sale of consumer healthcare business

Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth some $15 billion up for grabs.

06 Oct 2017

EU drugs agency, seeking staff, warns of Brexit budget hit

LONDON Europe's drugs regulator has issued a 31.8 million-pound ($42 million) tender for temporary workers and warned it could face a major budget hit as it struggles with the fallout of Brexit, which will uproot it from London.

05 Oct 2017

Drug industry gives up legal battle over new UK cost curbs

LONDON Britain's pharmaceuticals industry has thrown in the towel in a legal battle over new cost curbs imposed by the state-run health service, after failing to secure a judicial review.

05 Oct 2017

Roche bladder cancer drug struggles as medics focus on survival

LONDON Roche's immunotherapy drug Tecentriq has lost market share to Merck & Co's rival Keytruda since a clinical trial showed the Swiss company's medicine failed to improve overall survival in bladder cancer.

05 Oct 2017

Microscope trailblazers win chemistry Nobel for 'freeze framing' life

STOCKHOLM/LONDON A trio of Swiss, American and British scientists won the 2017 Nobel chemistry prize on Wednesday for developing cryo-electron microscopy, allowing researchers to see biological molecules frozen in action. | Video

04 Oct 2017

Drug industry fails to win judicial review of new UK cost curbs

LONDON, Oct 4 Britain's pharmaceuticals industry failed to secure a judicial review of new cost curbs, which mean drugs costing NHS England more than 20 million pounds ($26 mln) annually no longer get automatic funding.

04 Oct 2017

U.S. trio win Nobel for finding Einstein's gravitational waves

STOCKHOLM/LONDON Three U.S. scientists won the 2017 Nobel prize for physics on Tuesday for opening up a new era of astronomy by detecting gravitational waves, ripples in space and time foreseen by Albert Einstein a century ago. | Video

03 Oct 2017

EU drugs head fears delays, health hazards as agency uprooted

LONDON Access to new medicines and safety checks on existing treatments will be jeopardized if politicians pick a new home for Europe's London-based drugs regulator that is unacceptable to staff, its executive director told Reuters.


  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 32,584.35 -- --%
Nikkei 21,448.52 + 85.47 +0.40%
Hang Seng 28,159.09 -552.67 -1.92%
EUR/INR 76.876 +0.28%
USD/INR 65 -0.06%
GBP/INR 85.657 -0.25%
Gold 1,279.90 +0.00 +0.00%
Oil 51.35 -0.69 -1.33%
Corn 349.75 +1.25 +0.36%